Literature DB >> 23268645

Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates.

Adam T Clay1, Frances J Sharom.   

Abstract

The ABC protein P-glycoprotein (Pgp or ABCB1) is a multidrug efflux pump capable of transporting many structurally diverse substrates from within the lipid bilayer. Previous studies have demonstrated the importance of the membrane in modulating Pgp function, but few have quantified these effects. We employed purified Pgp reconstituted into phospholipid bilayers with defined gel to liquid-crystalline melting transitions to investigate the effect of membrane environment on the transporter and three of its substrates. Equilibrium dialysis measurements indicated that Hoechst 33342, LDS-751, and MK-571 partitioned much more readily into liquid-crystalline phase bilayers than into gel phase bilayers. However, drug binding affinities revealed that Pgp bound the three substrates more tightly when the lipid bilayer was in the gel phase. The binding affinity of the transporter for substrates within the bilayer was low, in the millimolar range, suggesting that it interacts with them weakly. Thermodynamic analysis revealed that both drug-Pgp and drug-lipid interactions contribute to binding affinity. The kinetics of LDS-751 and Hoechst 33342 transport by reconstituted Pgp was monitored using a real-time fluorescence-based assay to obtain apparent turnover frequencies. Transport rates were found to be sensitive to both drug structure and lipid environment. Arrhenius and transition state analysis of transport rates suggested that the rate of drug transport depends on both the affinity of Pgp for substrate and protein conformational changes. Transport rates did not appear to be limited exclusively by the rate of ATP hydrolysis and may be partially controlled by the rate of drug dissociation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23268645     DOI: 10.1021/bi301532c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

2.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

3.  Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids.

Authors:  Vijay Raghavan; Sivakumar Vijayaraghavalu; Chiranjeevi Peetla; Masayoshi Yamada; Megan Morisada; Vinod Labhasetwar
Journal:  Langmuir       Date:  2015-10-15       Impact factor: 3.882

Review 4.  Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Authors:  Chiranjeevi Peetla; Sivakumar Vijayaraghavalu; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2013-09-19       Impact factor: 15.470

5.  Membrane Assays to Characterize Interaction of Drugs with ABCB1.

Authors:  Zsolt Fekete; Zsuzsanna Rajnai; Tünde Nagy; Katalin Tauberné Jakab; Anita Kurunczi; Katalin Gémes; Krisztina Herédi-Szabó; Ferenc Fülöp; Gábor K Tóth; Maciej Czerwinski; Greg Loewen; Peter Krajcsi
Journal:  J Membr Biol       Date:  2015-04-30       Impact factor: 1.843

6.  Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein.

Authors:  Laura A Wilt; Diana Nguyen; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2017-03-07       Impact factor: 3.534

7.  Cell-free microfluidic determination of P-glycoprotein interactions with substrates and inhibitors.

Authors:  Klaus Eyer; Michael Herger; Stefanie D Krämer; Petra S Dittrich
Journal:  Pharm Res       Date:  2014-06-14       Impact factor: 4.200

8.  Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

Authors:  Dana Emmert; Christopher R Campos; David Ward; Peihua Lu; Hilda A Namanja; Kelsey Bohn; David S Miller; Frances J Sharom; Jean Chmielewski; Christine A Hrycyna
Journal:  ACS Chem Neurosci       Date:  2014-02-07       Impact factor: 4.418

9.  A subset of annular lipids is linked to the flippase activity of an ABC transporter.

Authors:  Chérine Bechara; Anne Nöll; Nina Morgner; Matteo T Degiacomi; Robert Tampé; Carol V Robinson
Journal:  Nat Chem       Date:  2015-02-02       Impact factor: 24.427

10.  Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pump.

Authors:  Julien Marcoux; Sheila C Wang; Argyris Politis; Eamonn Reading; Jerome Ma; Philip C Biggin; Min Zhou; Houchao Tao; Qinghai Zhang; Geoffrey Chang; Nina Morgner; Carol V Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.